Skip to main content
Erschienen in: Der Urologe 3/2012

01.03.2012 | Leitthema

Metastasenresektion beim Prostatakarzinom

verfasst von: C.-H. Ohlmann, S. Siemer, M. Stöckle

Erschienen in: Die Urologie | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Resektion singulärer bzw. zahlenmäßig begrenzter Metastasen stellt beim Prostatakarzinom eine Kontroverse dar, die zunehmend diskutiert wird. Grund hierfür ist v. a. die verbesserte Lokalisationsdiagnostik mittels Cholin-PET/CT, die auch in niedrigen PSA-Bereichen die Lokalisation von Lymphknoten- bzw. Organmetastasen ermöglicht. Neben der Resektion synchroner Metastasen zum Zeitpunkt der Prostatektomie stellt sich die Frage nach der onkologischen Effektivität einer Salvagelymphknotenresektion bzw. der Salvageresektion viszeraler oder ossärer Metastasen. Nur für die Resektion synchroner Lymphknotenmetastasen kann anhand der aktuellen Datenlage ein Überlebensvorteil angenommen werden. Für die Salvagelymphadenektomie oder die Salvageresektion viszeraler oder ossärer Metastasen ist die Datenlage jedoch noch nicht zufrieden stellend, so dass hierfür noch keine generelle Empfehlung gegeben werden kann. In diesem Artikel werden vorhandenen Daten zur Metastasenresektion in den verschiedenen klinischen Szenarien unter Berücksichtigung der Empfehlungen der aktuellen deutschen und europäischen Leitlinien zusammengefasst.
Literatur
1.
Zurück zum Zitat Ljungberg B, Cowan NC, Hanbury DC et al (2010) EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 58:398–406PubMedCrossRef Ljungberg B, Cowan NC, Hanbury DC et al (2010) EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 58:398–406PubMedCrossRef
2.
Zurück zum Zitat Deutsche Gesellschaft für Urologie e. V. (2011) Interdisziplinäre Leitlinie der Qualität S3 zur Früherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms. DGU, Berlin, http://www.awmf.org/uploads/tx_szleitlinien/043–022-OL-l_S3_Prostatakarzinom_Langfassung_V1–03.pdf Deutsche Gesellschaft für Urologie e. V. (2011) Interdisziplinäre Leitlinie der Qualität S3 zur Früherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms. DGU, Berlin, http://​www.​awmf.​org/​uploads/​tx_​szleitlinien/​043–022-OL-l_S3_Prostatakarzinom_Langfassung_V1–03.pdf
3.
Zurück zum Zitat Mottet N, Bellmunt J, Bolla M et al (2011) EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 59:572–583PubMedCrossRef Mottet N, Bellmunt J, Bolla M et al (2011) EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 59:572–583PubMedCrossRef
4.
Zurück zum Zitat Saitoh H, Hida M, Shimbo T et al (1984) Metastatic patterns of prostatic cancer. Correlation between sites and number of organs involved. Cancer 54:3078–3084PubMedCrossRef Saitoh H, Hida M, Shimbo T et al (1984) Metastatic patterns of prostatic cancer. Correlation between sites and number of organs involved. Cancer 54:3078–3084PubMedCrossRef
5.
Zurück zum Zitat Picchio M, Briganti A, Fanti S et al (2011) The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer. Eur Urol 59:51–60PubMedCrossRef Picchio M, Briganti A, Fanti S et al (2011) The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer. Eur Urol 59:51–60PubMedCrossRef
6.
Zurück zum Zitat Heidenreich A, Aus G, Bolla M et al (2008) EAU guidelines on prostate cancer. Eur Urol 53:68–80PubMedCrossRef Heidenreich A, Aus G, Bolla M et al (2008) EAU guidelines on prostate cancer. Eur Urol 53:68–80PubMedCrossRef
7.
Zurück zum Zitat Ghavamian R, Bergstralh EJ, Blute ML et al (1999) Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alone for pTxN+ prostate cancer: a matched comparison. J Urol 161:1223–1228PubMedCrossRef Ghavamian R, Bergstralh EJ, Blute ML et al (1999) Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alone for pTxN+ prostate cancer: a matched comparison. J Urol 161:1223–1228PubMedCrossRef
8.
Zurück zum Zitat Engel J, Bastian PJ, Baur H et al (2010) Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer. Eur Urol 57:754–761PubMedCrossRef Engel J, Bastian PJ, Baur H et al (2010) Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer. Eur Urol 57:754–761PubMedCrossRef
9.
Zurück zum Zitat Bader P, Burkhard FC, Markwalder R, Studer UE (2003) Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol 169:849–854PubMedCrossRef Bader P, Burkhard FC, Markwalder R, Studer UE (2003) Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol 169:849–854PubMedCrossRef
10.
Zurück zum Zitat Cheng L, Zincke H, Blute ML et al (2001) Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer 91:66–73PubMedCrossRef Cheng L, Zincke H, Blute ML et al (2001) Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer 91:66–73PubMedCrossRef
11.
Zurück zum Zitat Daneshmand S, Quek ML, Stein JP et al (2004) Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol 172:2252–2255PubMedCrossRef Daneshmand S, Quek ML, Stein JP et al (2004) Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol 172:2252–2255PubMedCrossRef
12.
Zurück zum Zitat Boorjian SA, Thompson RH, Siddiqui S et al (2007) Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. J Urol 178:861–870CrossRef Boorjian SA, Thompson RH, Siddiqui S et al (2007) Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. J Urol 178:861–870CrossRef
13.
Zurück zum Zitat Zwergel U, Lehmann J, Wullich B et al (2004) Lymph node positive prostate cancer: long-term survival data after radical prostatectomy. J Urol 171:1128–1131PubMedCrossRef Zwergel U, Lehmann J, Wullich B et al (2004) Lymph node positive prostate cancer: long-term survival data after radical prostatectomy. J Urol 171:1128–1131PubMedCrossRef
14.
Zurück zum Zitat Heidenreich A, Bellmunt J, Bolla M et al (2011) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 59:61–71PubMedCrossRef Heidenreich A, Bellmunt J, Bolla M et al (2011) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 59:61–71PubMedCrossRef
15.
Zurück zum Zitat Heidenreich A, Bolla M, Joniau S et al (2011) Guidelines on prostate cancer. Eur Urol 59:572–583, http://www.uroweb.org/gls/pdf/08_Prostate_Cancer%20September%2022nd%202011.pdf Heidenreich A, Bolla M, Joniau S et al (2011) Guidelines on prostate cancer. Eur Urol 59:572–583, http://​www.​uroweb.​org/​gls/​pdf/​08_​Prostate_​Cancer%20September%2022nd%202011.pdf
16.
Zurück zum Zitat Schilling D, Schlemmer HP, Wagner PH et al (2008) Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer. BJU Int 102:446–451PubMedCrossRef Schilling D, Schlemmer HP, Wagner PH et al (2008) Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer. BJU Int 102:446–451PubMedCrossRef
17.
Zurück zum Zitat Martini T, Mayr R, Trenti E et al (2012) The Role of C-Choline-PET/CT-Guided Secondary Lymphadenectomy in Patients with PSA Failure after Radical Prostatectomy: Lessons Learned from Eight Cases. Adv Urol 2012:601572PubMed Martini T, Mayr R, Trenti E et al (2012) The Role of C-Choline-PET/CT-Guided Secondary Lymphadenectomy in Patients with PSA Failure after Radical Prostatectomy: Lessons Learned from Eight Cases. Adv Urol 2012:601572PubMed
18.
Zurück zum Zitat Rigatti P, Suardi N, Briganti A et al (2011) Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography. Eur Urol 60:935–943PubMedCrossRef Rigatti P, Suardi N, Briganti A et al (2011) Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography. Eur Urol 60:935–943PubMedCrossRef
19.
Zurück zum Zitat Rinnab L, Simon J, Hautmann RE et al (2009) [(11)C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy. World J Urol 27:619–625PubMedCrossRef Rinnab L, Simon J, Hautmann RE et al (2009) [(11)C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy. World J Urol 27:619–625PubMedCrossRef
20.
Zurück zum Zitat Winter A, Uphoff J, Henke RP, Wawroschek F (2010) First results of [11C]choline PET/CT-guided secondary lymph node surgery in patients with PSA failure and single lymph node recurrence after radical retropubic prostatectomy. Urol Int 84:418–423PubMedCrossRef Winter A, Uphoff J, Henke RP, Wawroschek F (2010) First results of [11C]choline PET/CT-guided secondary lymph node surgery in patients with PSA failure and single lymph node recurrence after radical retropubic prostatectomy. Urol Int 84:418–423PubMedCrossRef
21.
Zurück zum Zitat Yamada T, Arimoto T, Komatani N, Hara H (2004) A case of solitary endobronchial metastasis of prostatic cancer. Nihon Kokyuki Gakkai Zasshi 42:961–965PubMed Yamada T, Arimoto T, Komatani N, Hara H (2004) A case of solitary endobronchial metastasis of prostatic cancer. Nihon Kokyuki Gakkai Zasshi 42:961–965PubMed
22.
Zurück zum Zitat Sakai T, Kimura D, Hatanaka R et al (2010) Surgical treated pulmonary metastasis from prostatic cancer; report of a case. Kyobu Geka 63:340–343PubMed Sakai T, Kimura D, Hatanaka R et al (2010) Surgical treated pulmonary metastasis from prostatic cancer; report of a case. Kyobu Geka 63:340–343PubMed
23.
Zurück zum Zitat Hofland CA, Bagg MD (2000) An isolated pulmonary metastasis in prostate cancer. Mil Med 165:973–974PubMed Hofland CA, Bagg MD (2000) An isolated pulmonary metastasis in prostate cancer. Mil Med 165:973–974PubMed
24.
Zurück zum Zitat Khandani AH, Funkhouser WK, Feins R, Socinski MA (2009) Simultaneous FDG PET+/Glut1+ lung and FDG PET-/Glut1- subcarinal lymph node metastases from prostate cancer. Ann Nucl Med 23:595–597PubMedCrossRef Khandani AH, Funkhouser WK, Feins R, Socinski MA (2009) Simultaneous FDG PET+/Glut1+ lung and FDG PET-/Glut1- subcarinal lymph node metastases from prostate cancer. Ann Nucl Med 23:595–597PubMedCrossRef
25.
Zurück zum Zitat Goto T, Maeshima A, Oyamada Y, Kato R (2010) Solitary pulmonary metastasis from prostate sarcomatoid cancer. World J Surg Oncol 8:101PubMedCrossRef Goto T, Maeshima A, Oyamada Y, Kato R (2010) Solitary pulmonary metastasis from prostate sarcomatoid cancer. World J Surg Oncol 8:101PubMedCrossRef
26.
Zurück zum Zitat Smith CP, Sharma A, Ayala G et al (1999) Solitary pulmonary metastasis from prostate cancer. J Urol 162:2102PubMedCrossRef Smith CP, Sharma A, Ayala G et al (1999) Solitary pulmonary metastasis from prostate cancer. J Urol 162:2102PubMedCrossRef
27.
Zurück zum Zitat Kohli M, Viswamitraa S, Schaefer R et al (2006) Metastasectomy for isolated bilateral adrenal metastases in hormone-refractory prostate cancer. Clin Adv Hematol Oncol 4:754–757PubMed Kohli M, Viswamitraa S, Schaefer R et al (2006) Metastasectomy for isolated bilateral adrenal metastases in hormone-refractory prostate cancer. Clin Adv Hematol Oncol 4:754–757PubMed
28.
Zurück zum Zitat Chao DH, Higgins JP, Brooks JD (2004) Biochemical remission after resection of prostate cancer lung metastasis. Urology 63:584–585PubMedCrossRef Chao DH, Higgins JP, Brooks JD (2004) Biochemical remission after resection of prostate cancer lung metastasis. Urology 63:584–585PubMedCrossRef
29.
Zurück zum Zitat Pruthi RS, Hubbard JS, Kouba E, Wallen E (2007) Androgen-independent prostate cancer treated with resection of the solitary metastatic site. Urol Int 79:371–373PubMedCrossRef Pruthi RS, Hubbard JS, Kouba E, Wallen E (2007) Androgen-independent prostate cancer treated with resection of the solitary metastatic site. Urol Int 79:371–373PubMedCrossRef
30.
Zurück zum Zitat Menchini-Fabris F, Giannarini G, Pomara G et al (2007) Testicular metastasis as isolated recurrence after radical prostatectomy. A first case. Int J Impot Res 19:108–109PubMedCrossRef Menchini-Fabris F, Giannarini G, Pomara G et al (2007) Testicular metastasis as isolated recurrence after radical prostatectomy. A first case. Int J Impot Res 19:108–109PubMedCrossRef
31.
Zurück zum Zitat Kwon SY, Jung HS, Lee JG et al (2011) Solitary testicular metastasis of prostate cancer mimicking primary testicular cancer. Korean J Urol 52:718–720PubMedCrossRef Kwon SY, Jung HS, Lee JG et al (2011) Solitary testicular metastasis of prostate cancer mimicking primary testicular cancer. Korean J Urol 52:718–720PubMedCrossRef
32.
Zurück zum Zitat Boyer BP, Boyer MJ (2009) An elusive tumor in a man who has evidence of prostate cancer metastasis. JAAPA 22:22–25PubMed Boyer BP, Boyer MJ (2009) An elusive tumor in a man who has evidence of prostate cancer metastasis. JAAPA 22:22–25PubMed
33.
Zurück zum Zitat Bromberg WD, Gaylis FD, Bauer KD, Schaeffer AJ (1989) Isolated pulmonary metastases from carcinoma of the prostate: a case report and deoxyribonucleic acid analysis using flow cytometry. J Urol 141:137–139PubMed Bromberg WD, Gaylis FD, Bauer KD, Schaeffer AJ (1989) Isolated pulmonary metastases from carcinoma of the prostate: a case report and deoxyribonucleic acid analysis using flow cytometry. J Urol 141:137–139PubMed
34.
Zurück zum Zitat Maeda T, Tateishi U, Komiyama M et al (2006) Distant metastasis of prostate cancer: early detection of recurrent tumor with dual-phase carbon-11 choline positron emission tomography/computed tomography in two cases. Jpn J Clin Oncol 36:598–601PubMedCrossRef Maeda T, Tateishi U, Komiyama M et al (2006) Distant metastasis of prostate cancer: early detection of recurrent tumor with dual-phase carbon-11 choline positron emission tomography/computed tomography in two cases. Jpn J Clin Oncol 36:598–601PubMedCrossRef
Metadaten
Titel
Metastasenresektion beim Prostatakarzinom
verfasst von
C.-H. Ohlmann
S. Siemer
M. Stöckle
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
Die Urologie / Ausgabe 3/2012
Print ISSN: 2731-7064
Elektronische ISSN: 2731-7072
DOI
https://doi.org/10.1007/s00120-012-2827-4

Weitere Artikel der Ausgabe 3/2012

Der Urologe 3/2012 Zur Ausgabe

Mitteilungen der DGU

Termine

Berufspolitik BDU

Berufspolitik BDU

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.